Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
847 19 |
Ultima descărcare din IBN: 2022-10-26 08:58 |
Căutarea după subiecte similare conform CZU |
615.225.2.035.1 (1) |
Medicamentele potrivit acţiunii lor principale (395) |
SM ISO690:2012 GHICAVÎI, Victor, BACHINSKY, N.G., PODGURSKY, L. A., ŢURCAN, Lucia, CHIANU, Marin. Selection of antihypertensive drugs from the perspective of clinical pharmacology. In: Moldovan Medical Journal, 2018, nr. 1(61), pp. 18-23. ISSN 2537-6373. DOI: https://doi.org/10.5281/zenodo.1186184 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Moldovan Medical Journal | ||||||
Numărul 1(61) / 2018 / ISSN 2537-6373 /ISSNe 2537-6381 | ||||||
|
||||||
DOI:https://doi.org/10.5281/zenodo.1186184 | ||||||
CZU: 615.225.2.035.1 | ||||||
Pag. 18-23 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background: The rational use of medicines remains one of the most important directions of public health, especially in socio-medical diseases, including arterial hypertension. Material and methods: The study involved 28 cardiologists and 84 internists who, based on a set of questionnaires, expressed their opinion on ambulatory treatment of patients with arterial hypertension. Also 21 internists, 6 cardiologists and 6 obstetrician-gynecologists expressed their opinion on treatment of pregnancy-induced hypertension. Results: Cardiologists and internists recommended angiotensin-converting-enzyme inhibitors (ACE inhibitors) in 28% of cases, diuretics – in 23% of cases, beta-blockers (BB) – in 20, 4% of cases, calcium channel blockers (CCB) – in 13.7% of cases, angiotensin receptor blockers (ARB) – in 13.6% of cases for ambulatory treatment of patients with arterial hypertension. The antihypertensive drugs from other pharmacological groups (with central action, alpha-blockers, arteriodilators, sympatholytics, etc.) were prescribed in only 1.3% of patients. On treatment of hypertension in pregnancy showed that all physicians – 100% recommended as first-line agent for treatment of hypertension during pregnancy centrally acting antihypertensive drug Methyldopa. For second-line treatment they recommended CCB – in 36.36% of cases, alpha-adrenoblockers – in 24.24% of cases, BB – in 21.21% of cases, diuretics – in 12.12% of cases and 3% for ACE inhibitors and ARB. For treatment pre-eclampsia and eclampsia seizures in 84.85% of cases is recommended Magnesium sulfate and 15.15% mention labetalol, hydralazine and sodium nitroprusside. Conclusions: ACE inhibitors, diuretics, BAB, CCB and ARB have been first-line drugs in the arterial hypertension (AHT) treatment. For treatment of pregnancy-induced hypertension physicians recommended centrally acting antihypertensive drug Methyldopa. For second-line treatment they recommended calcium channel blockers (CCB), alpha-adrenoblockers, beta-blockers (BB) and diuretics. As third-choice in treatment of severe hypertension in preeclampsia are selected direct vasodilators as hydralazine, labetalol, sodium nitroprusside, and the most widely used in preeclampsia and eclampsia remains magnesium sulfate. |
||||||
Cuvinte-cheie arterial hypertension, antihypertensive drugs, angiotensin-converting-enzyme inhibitors |
||||||
|
Crossref XML Export
<?xml version='1.0' encoding='utf-8'?> <doi_batch version='4.3.7' xmlns='http://www.crossref.org/schema/4.3.7' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.crossref.org/schema/4.3.7 http://www.crossref.org/schema/deposit/crossref4.3.7.xsd'> <head> <doi_batch_id>ibn-61324</doi_batch_id> <timestamp>1713588773</timestamp> <depositor> <depositor_name>Information Society Development Instiute, Republic of Moldova</depositor_name> <email_address>idsi@asm.md</email_address> </depositor> <registrant>Asociaţia Stiinţifică Medicală din Modova</registrant> </head> <body> <journal> <journal_metadata> <full_title>Moldovan Medical Journal</full_title> <issn media_type='print'>25376373</issn> </journal_metadata> <journal_issue> <publication_date media_type='print'> <year>2018</year> </publication_date> <issue>1(61)</issue> </journal_issue> <journal_article publication_type='full_text'><titles> <title>Selection of antihypertensive drugs from the perspective of clinical pharmacology</title> </titles> <contributors> <person_name sequence='first' contributor_role='author'> <given_name>Victor</given_name> <surname>Ghicavâi</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Nicolae</given_name> <surname>Bacinschi</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Lilia</given_name> <surname>Podgurschi</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Lucia</given_name> <surname>Ţurcan</surname> </person_name> <person_name sequence='additional' contributor_role='author'> <given_name>Marin</given_name> <surname>Chianu</surname> </person_name> </contributors> <publication_date media_type='print'> <year>2018</year> </publication_date> <pages> <first_page>18</first_page> <last_page>23</last_page> </pages> <doi_data> <doi>10.5281/zenodo.1186184</doi> <resource>http://www.crossref.org/</resource> </doi_data> </journal_article> </journal> </body> </doi_batch>